This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Litigation Powerhouse: Covington & Burling

August 12, 2016, Law360

John Hall, Paul Schmidt, Michael Imbroscio, and Stephen Anthony are quoted in the Law360 profile of the firm for the “Litigation Powerhouse” series. According to Hall, “What we have that other firms don't have is this incredible depth of regulatory and prior government experience that we bring to bear in almost all of our matters.”

Schmidt, commenting on the firm’s work on behalf of Eli Lilly in its Cymbalta litigation says, “We were able to try three cases back-to-back because we have a really strong team.” He continues, “We work really well together and pride ourselves on being able to adapt quickly.”

Speaking about the importance of experience, especially in relation to work on behalf of La Roche in Accutane litigation, Imbroscio says, “We bring to our appeals a combination of knowing this medicine well and knowing the kinds of issues that are important to press at trial and ultimately on appeal.”

Anthony adds, “Our thorough knowledge of the life sciences industry is something that not only our food and drug regulatory lawyers can be proud of — it also helps our litigators handle our clients' most complicated cases." He also notes that the firm's successful “home-grown” litigators — including the Cymbalta defense team — draw clients with their track records. “They live and breathe working in a courtroom and communicating to judges and juries all around the country.” He continues, “When clients see them in action and see the results they get, they want to send us more work.”

“Everything in our firm is designed to promote collaboration and cooperation towards achieving the best result for the client,” Hall concludes. “More and more in recent years, that aspect of how we operate has become its own advantage.”


Share this article: